Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

In 2016

Date:

29 Aug,2022


6 Month, Established a strategic partnership with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences —— "New Drug for Alzheimer's Disease FN12 》Project Signing

Previous page

2017

2015

Next page

Related Recommendations

Image Name

2021/03/02

Traveling thousands of miles across provinces to pick you up! Wanbangde Pharmaceutical Group’s special shuttle bus returns to work, directly transporting employees back to their hometowns.

Image Name

2021/03/02

Environmental Impact Assessment Report for the 980-Ton Per Year Norfloxacin Production Technology Upgrade Project (Front-end Supplement) of Wanbangde Pharmaceutical Group Co., Ltd.

Image Name

2021/03/02

Lü Zhiliang, Minister of Organization and Standing Committee Member of the Taizhou Municipal Party Committee, visited Wanbangde Pharmaceutical Group to coordinate and address challenges hindering the company's development.

< 1...434445...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38